Brief: Cipher Pharmaceuticals Q1 net loss per basic share $0.10
05/05/2016 12:00
May 5 (Reuters) - Cipher Pharmaceuticals Inc CPH.TO
* Cipher Pharmaceuticals reports Q1 2016 financial results
* Qtrly total revenue increased 23% to $9.1 million from
$7.4 million
* Qtrly net loss per basic share $0.10
Source text for Eikon: ID:nPn7n7YTpa
Further company coverage: CPH.TO
(Bengaluru Newsroom: +1 646 223 8780)
Recent news on Cipher Pharmaceuticals
See all newsBrief: Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award
Canada's Cipher Pharma Q2 revenue falls on lower Natroba sales amid reduced Medicaid coverage
Canada Research Roundup: Altius Minerals, Cipher Pharmaceuticals, Suncor Energy
Canada's Cipher Pharmaceuticals Q1 net income jumps 135% on lower costs
Brief: Cipher Pharmaceuticals Q1 Net Income USD 6.163 Million